+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Luanshi Guntan Pills Market by Form (Capsule, Pill, Tablet), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Product Type, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6127311
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The landscape surrounding Luanshi Guntan Pills is anchored in centuries of traditional formulation, yet it is increasingly shaped by modern scientific validation and evolving patient demand. Originally rooted in millennia-old herbal compounding practices, these pills have undergone rigorous scrutiny by regulatory authorities, propelling them from regional remedies to widely recognized therapeutic adjuncts. Across key markets, stakeholders including healthcare practitioners, formulary committees, and patient advocacy groups are converging around a unified narrative: the integration of traditional herbal efficacy with evidence-based practice. This convergence underscores the imperative for a nuanced understanding of product portfolios and differentiation strategies in order to navigate competitive pressures.

Charting the Digital and Technological Catalysts That Are Redefining Traditional Medicine Adoption and Industry Dynamics

Over recent years, the transformation of the Luanshi Guntan Pills market has been nothing short of revolutionary, driven by a convergence of digital health platforms, precision manufacturing, and a renewed appreciation for integrative wellness. Advancements in extraction technology have elevated the consistency and potency of key herbal actives, bolstering confidence among regulatory bodies and clinical investigators alike. Meanwhile, digital channels have broadened patient access, enabling direct engagement through telemedicine consultations and branded e-commerce portals. Consequently, stakeholders are reimagining traditional supply chains, shifting from fragmented distribution networks to end-to-end digital fulfillment models that heighten transparency and traceability.

Dissecting How United States 2025 Tariffs on Herbal Constituents Have Reshaped Supply Chains and Pricing Imperatives

In 2025, the imposition of supplementary tariffs on herbal constituents and excipients in Luanshi Guntan Pills by the United States introduced a material inflection point for manufacturers and distributors. The additional duties, targeting raw ingredient lines sourced from key Asian markets, exerted upward pressure on production costs and prompted recalibrations of global sourcing strategies. Some firms responded by diversifying their supply base, forging relationships with certified growers in emerging geographies, whereas others absorbed incremental expenses to maintain price stability and market share.

Comprehensive Segmentation Analysis Illuminating How Formulation, Channel, Product Type, and End User Converge to Drive Market Pivots

Segmental behavior in the Luanshi Guntan Pills sphere reveals layered preferences that inform product development and go-to-market maneuvers. When considering form, differentiation extends beyond a simple capsule-pill-tablet taxonomy into sub-types such as hard shell capsules versus soft gels, coated versus uncoated pills, and enteric-coated alongside scored tablets. Each variant carries distinct release profiles and manufacturing complexities that align with patient tolerability and dosage regimens. Distribution channels have likewise evolved, encompassing traditional hospital pharmacies alongside expanding online pharmacy ecosystems that blend direct-to-consumer e-commerce platforms with health portals, while retail segments split across national chain outlets and community-focused independents. Within product type, the spectrum ranges from Chinese herbal extracts-segregated into compound blends and single herb isolates-to patent medicines formulated under proprietary intellectual property licenses, as well as traditional multi-herb formulas and branded proprietary blends. End-user segmentation further stratifies demand: community and specialty clinics often drive prescribed usage; chain and independent drug stores facilitate over-the-counter sales; and private and public hospitals leverage formulary committees to guide institutional purchasing. Together, these intersecting dimensions map a complex market fabric in which each segment contributes discrete insights to inform tailored commercialization strategies.

Illuminating Regional Dynamics from Americas to Asia-Pacific to Inform Tailored Expansion and Regulatory Strategies

Regionally, the Americas stand at the forefront of premium pricing dynamics and patient acceptance, propelled by robust regulatory frameworks and sophisticated distribution infrastructures. In North America, increasing collaboration between herbal medicine advocates and clinical research institutions underscores a shift toward hybrid treatment protocols. Across Latin America, market participants are capitalizing on longstanding cultural affinities for botanical remedies to expand reach, despite logistical challenges in rural distribution. In the Europe, Middle East & Africa cluster, disparate regulatory regimes challenge harmonization, yet nascent cross-border partnerships and shared pharmacopoeia standards are steadily reducing barriers. European markets emphasize rigorous clinical validation and quality compliance, whereas Middle Eastern and African markets present opportunities for scaled manufacturing partnerships, buoyed by government-led initiatives to diversify pharmaceutical portfolios. Asia-Pacific remains the largest consumption hub, driven by established traditional medicine practices in China and increasing adoption in Southeast Asia. Emerging economies in the region are witnessing accelerated penetration of online pharmacies and mobile health solutions, forging new pathways to consumer engagement. This regional mosaic demonstrates that nuanced market entry and expansion strategies must account for regulatory variability, cultural acceptance, and distribution maturity in each geography.

Delving into Competitive Tactics Where Extraction Innovations and Strategic Partnerships Are Forging Sustainable Market Leadership

Major players in the Luanshi Guntan Pills domain are crafting competitive moats through differentiated pipelines, strategic alliances, and targeted geographic expansions. Some organizations are investing heavily in next-generation extraction platforms to capture higher purity levels and improve bioavailability, while others are establishing joint ventures with academic research centers to substantiate clinical claims. Intellectual property strategies vary, with select firms filing for method-of-use patents and proprietary formula trademarks in priority markets. Concurrently, distribution partnerships are being realigned: global integrators are collaborating with specialized local distributors to gain market penetration, whereas digital-first enterprises are negotiating exclusivity agreements with e-commerce portals to accelerate direct-to-consumer roll-out. Corporate M&A activity has remained selective, focusing on bolt-on acquisitions that enhance formulation expertise or add complementary product portfolios. Across the competitive landscape, the emphasis on quality certifications-such as GMP, ISO, and traditional medicine pharmacopoeia monographs-serves as a critical differentiator in negotiations with institutional buyers and healthcare professionals.

Actionable Strategic Imperatives for Industry Stakeholders to Capitalize on Emerging Trends and Fortify Competitive Advantage

To excel in the evolving Luanshi Guntan Pills marketplace, industry leaders must execute on several strategic imperatives. First, investing in advanced analytics and digital manufacturing platforms can enhance supply chain visibility and enable real-time quality control, mitigating the risks associated with tariff volatility and cross-border logistics. Simultaneously, fostering collaborative research alliances with clinical institutions will accelerate evidence generation and support premium positioning in sophisticated markets. Embracing omnichannel distribution strategies-integrating hospital, retail, and direct-to-consumer channels-will deliver seamless patient experiences and maximize brand reach. Moreover, prioritizing sustainability, from ethical sourcing of herbs to eco-friendly packaging solutions, will resonate with environmentally conscious stakeholders and regulators. Finally, cultivating a robust intellectual property portfolio around unique formulations and delivery technologies will create defensible differentiation, underpinning long-term revenue growth.

Rigorous Mixed-Method Research Protocols Leveraging Primary Interviews and Comprehensive Secondary Data for Robust Market Intelligence

This research synthesis derives from a mixed-methodology approach, integrating both primary and secondary data streams. Primary insights were gathered through in-depth interviews with industry veterans, key opinion leaders in traditional medicine, and senior executives responsible for procurement and R&D. Field visits to manufacturing sites and distribution centers provided observational data on operational best practices and logistical challenges. Secondary research encompassed peer-reviewed journals, regulatory filings, pharmacopoeia monographs, and publicly available financial disclosures, all subjected to rigorous validation protocols. Market intelligence was further triangulated via proprietary databases and cross-referenced with customer usage patterns and formulary inclusion criteria. Each segmentation dimension was analyzed through detailed criteria definitions, ensuring consistent data granularity. In addition, quality assurance measures included peer review by an independent panel of subject matter experts to safeguard analytical robustness and mitigate bias.

Synthesizing Critical Market Drivers and Strategic Pathways to Navigate the Transformative Era of Luanshi Guntan Pills

In sum, the landscape for Luanshi Guntan Pills is at a strategic inflection, shaped by regulatory shifts, digital transformation, and evolving consumer paradigms. Market participants that deftly navigate the trade-offs between traditional authenticity and scientific validation will capture the premium segments, while those who optimize cross-border sourcing and distribution can mitigate the impact of geopolitical headwinds. Insight into nuanced segmentation layers empowers stakeholders to tailor product development, marketing, and channel strategies to distinct customer cohorts. The regional outlook underscores the importance of adaptive market entry tactics, with differentiated approaches needed across the Americas, Europe, Middle East & Africa, and the Asia-Pacific. Ultimately, a research-driven, partnership-oriented framework will underpin sustainable growth, enabling industry leaders to anticipate shifts, innovate responsibly, and maintain a competitive edge in this dynamic therapeutic arena.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Form
    • Capsule
      • Hard Shell Capsule
      • Soft Gel Capsule
    • Pill
      • Coated Pill
      • Uncoated Pill
    • Tablet
      • Enteric-Coated Tablet
      • Scored Tablet
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
      • E-Commerce Platform
      • Health Portal
    • Retail Pharmacy
      • Chain Pharmacy
      • Independent Pharmacy
  • Product Type
    • Chinese Herbal Extract
      • Compound Extract
      • Single Herb Extract
    • Patent Medicine
    • Traditional Compound
      • Multi Herb Formula
      • Proprietary Blend
  • End User
    • Clinics
      • Community Clinics
      • Specialty Clinics
    • Drug Stores
      • Chain Drug Stores
      • Independent Drug Stores
    • Hospitals
      • Private Hospitals
      • Public Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • China National Pharmaceutical Group Co., Ltd.
  • Beijing Tong Ren Tang Co., Ltd.
  • Harbin Pharmaceutical Group Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • Tasly Pharmaceutical Group Co., Ltd.
  • Guangzhou Pharmaceutical Holdings Limited
  • Shijiazhuang Yiling Pharmaceutical Co., Ltd.
  • Shandong Buchang Pharmaceuticals Co., Ltd.
  • Zhejiang Kangyou Pharmaceutical Co., Ltd.
  • Shanxi Pien Tze Huang Pharmaceutical Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in online patient communities sharing user experiences and dosage hacks for Luanshi Guntan Pills
5.2. Collaboration between traditional Chinese medicine practitioners and telemedicine platforms to prescribe Luanshi Guntan Pills
5.3. Advances in phytochemical standardization processes ensuring consistent potency in Luanshi Guntan Pills batches
5.4. Growing consumer preference for sustainably sourced herbal ingredients in Luanshi Guntan Pills formulations
5.5. Impact of regulatory harmonization between China and ASEAN on cross-border distribution of Luanshi Guntan Pills
5.6. Integration of AI-driven diagnostic tools with Luanshi Guntan Pills treatment plans for gastric disorders
5.7. Expansion of e-commerce partnerships driving targeted marketing campaigns for Luanshi Guntan Pills abroad
5.8. Development of novel delivery systems such as microencapsulation to enhance bioavailability of Luanshi Guntan Pills
5.9. Rising demand for clinical trial data to support efficacy claims of Luanshi Guntan Pills among healthcare providers
5.10. Emergence of personalized herbal prescriptions combining Luanshi Guntan Pills with complementary supplements based on microbiome profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Luanshi Guntan Pills Market, by Form
8.1. Introduction
8.2. Capsule
8.2.1. Hard Shell Capsule
8.2.2. Soft Gel Capsule
8.3. Pill
8.3.1. Coated Pill
8.3.2. Uncoated Pill
8.4. Tablet
8.4.1. Enteric-Coated Tablet
8.4.2. Scored Tablet
9. Luanshi Guntan Pills Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.3.1. E-Commerce Platform
9.3.2. Health Portal
9.4. Retail Pharmacy
9.4.1. Chain Pharmacy
9.4.2. Independent Pharmacy
10. Luanshi Guntan Pills Market, by Product Type
10.1. Introduction
10.2. Chinese Herbal Extract
10.2.1. Compound Extract
10.2.2. Single Herb Extract
10.3. Patent Medicine
10.4. Traditional Compound
10.4.1. Multi Herb Formula
10.4.2. Proprietary Blend
11. Luanshi Guntan Pills Market, by End User
11.1. Introduction
11.2. Clinics
11.2.1. Community Clinics
11.2.2. Specialty Clinics
11.3. Drug Stores
11.3.1. Chain Drug Stores
11.3.2. Independent Drug Stores
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Americas Luanshi Guntan Pills Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Luanshi Guntan Pills Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Luanshi Guntan Pills Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. China National Pharmaceutical Group Co., Ltd.
15.3.2. Beijing Tong Ren Tang Co., Ltd.
15.3.3. Harbin Pharmaceutical Group Co., Ltd.
15.3.4. Yunnan Baiyao Group Co., Ltd.
15.3.5. Tasly Pharmaceutical Group Co., Ltd.
15.3.6. Guangzhou Pharmaceutical Holdings Limited
15.3.7. Shijiazhuang Yiling Pharmaceutical Co., Ltd.
15.3.8. Shandong Buchang Pharmaceuticals Co., Ltd.
15.3.9. Zhejiang Kangyou Pharmaceutical Co., Ltd.
15.3.10. Shanxi Pien Tze Huang Pharmaceutical Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. LUANSHI GUNTAN PILLS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. LUANSHI GUNTAN PILLS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. LUANSHI GUNTAN PILLS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. LUANSHI GUNTAN PILLS MARKET: RESEARCHAI
FIGURE 24. LUANSHI GUNTAN PILLS MARKET: RESEARCHSTATISTICS
FIGURE 25. LUANSHI GUNTAN PILLS MARKET: RESEARCHCONTACTS
FIGURE 26. LUANSHI GUNTAN PILLS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LUANSHI GUNTAN PILLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY HARD SHELL CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY HARD SHELL CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY SOFT GEL CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY SOFT GEL CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY COATED PILL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY COATED PILL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY UNCOATED PILL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY UNCOATED PILL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY ENTERIC-COATED TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY ENTERIC-COATED TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY SCORED TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY SCORED TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY E-COMMERCE PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY E-COMMERCE PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY HEALTH PORTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY HEALTH PORTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY COMPOUND EXTRACT, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY COMPOUND EXTRACT, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY SINGLE HERB EXTRACT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY SINGLE HERB EXTRACT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PATENT MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PATENT MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY MULTI HERB FORMULA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY MULTI HERB FORMULA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PROPRIETARY BLEND, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PROPRIETARY BLEND, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY COMMUNITY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY COMMUNITY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CHAIN DRUG STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY CHAIN DRUG STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY INDEPENDENT DRUG STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY INDEPENDENT DRUG STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES LUANSHI GUNTAN PILLS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 161. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 162. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 163. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 164. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 165. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2018-2024 (USD MILLION)
TABLE 166. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2025-2030 (USD MILLION)
TABLE 167. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 168. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 169. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2018-2024 (USD MILLION)
TABLE 178. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2025-2030 (USD MILLION)
TABLE 179. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2018-2024 (USD MILLION)
TABLE 180. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2025-2030 (USD MILLION)
TABLE 181. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 184. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 185. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2018-2024 (USD MILLION)
TABLE 186. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2025-2030 (USD MILLION)
TABLE 187. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 188. CANADA LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 190. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 191. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2018-2024 (USD MILLION)
TABLE 194. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2025-2030 (USD MILLION)
TABLE 195. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 196. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 197. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 200. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 201. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2018-2024 (USD MILLION)
TABLE 206. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2025-2030 (USD MILLION)
TABLE 207. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2018-2024 (USD MILLION)
TABLE 208. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2025-2030 (USD MILLION)
TABLE 209. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2018-2024 (USD MILLION)
TABLE 214. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2025-2030 (USD MILLION)
TABLE 215. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA LUANSHI GUNTAN PILLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY PILL, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY TABLET, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 316. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2018-2024 (USD MILLION)
TABLE 320. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY CHINESE HERBAL EXTRACT, 2025-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2018-2024 (USD MILLION)
TABLE 322. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY TRADITIONAL COMPOUND, 2025-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 326. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2018-2024 (USD MILLION)
TABLE 328. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY DRUG STORES, 2025-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 330. UNITED KINGDOM LUANSHI GUNTAN PILLS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 331. GERMANY LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 332. GERMANY LUANSHI GUNTAN PILLS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 333. GERMANY LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 334. GERMANY LUANSHI GUNTAN PILLS MARKET SIZE, BY CAPSULE, 2025-2030 (USD MI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Luanshi Guntan Pills market report include:
  • China National Pharmaceutical Group Co., Ltd.
  • Beijing Tong Ren Tang Co., Ltd.
  • Harbin Pharmaceutical Group Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • Tasly Pharmaceutical Group Co., Ltd.
  • Guangzhou Pharmaceutical Holdings Limited
  • Shijiazhuang Yiling Pharmaceutical Co., Ltd.
  • Shandong Buchang Pharmaceuticals Co., Ltd.
  • Zhejiang Kangyou Pharmaceutical Co., Ltd.
  • Shanxi Pien Tze Huang Pharmaceutical Co., Ltd.